Valerio Gristina

1.4k total citations
54 papers, 809 citations indexed

About

Valerio Gristina is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Valerio Gristina has authored 54 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 25 papers in Cancer Research and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Valerio Gristina's work include Cancer Genomics and Diagnostics (20 papers), Lung Cancer Treatments and Mutations (20 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Valerio Gristina is often cited by papers focused on Cancer Genomics and Diagnostics (20 papers), Lung Cancer Treatments and Mutations (20 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Valerio Gristina collaborates with scholars based in Italy, United States and France. Valerio Gristina's co-authors include Antonio Galvano, Viviana Bazan, Nadia Barraco, Antonio Russo, Umberto Malapelle, Francesco Pepe, Pasquale Pisapia, Giancarlo Troncone, Antonio Russo and Lorena Incorvaia and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Valerio Gristina

49 papers receiving 798 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Valerio Gristina Italy 15 460 414 341 298 70 54 809
Danilo Rocco Italy 17 562 1.2× 537 1.3× 386 1.1× 311 1.0× 96 1.4× 55 995
Kuniko Sunami Japan 16 297 0.6× 320 0.8× 196 0.6× 150 0.5× 81 1.2× 47 638
Bethany Pitcher Canada 16 402 0.9× 516 1.2× 237 0.7× 337 1.1× 104 1.5× 27 832
Joao V. Alessi United States 14 373 0.8× 492 1.2× 214 0.6× 229 0.8× 89 1.3× 57 709
Giulia Barletta Italy 18 301 0.7× 408 1.0× 202 0.6× 228 0.8× 52 0.7× 44 702
Janice F. Eakle United States 9 345 0.8× 565 1.4× 265 0.8× 246 0.8× 76 1.1× 22 805
Giuliana Restante Italy 13 328 0.7× 322 0.8× 297 0.9× 340 1.1× 39 0.6× 25 721
Antonino Iaccarino Italy 18 321 0.7× 394 1.0× 333 1.0× 376 1.3× 97 1.4× 58 1.0k
Jinpeng Shi China 13 446 1.0× 566 1.4× 169 0.5× 261 0.9× 57 0.8× 27 840

Countries citing papers authored by Valerio Gristina

Since Specialization
Citations

This map shows the geographic impact of Valerio Gristina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valerio Gristina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valerio Gristina more than expected).

Fields of papers citing papers by Valerio Gristina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valerio Gristina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valerio Gristina. The network helps show where Valerio Gristina may publish in the future.

Co-authorship network of co-authors of Valerio Gristina

This figure shows the co-authorship network connecting the top 25 collaborators of Valerio Gristina. A scholar is included among the top collaborators of Valerio Gristina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valerio Gristina. Valerio Gristina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Incorvaia, Lorena, Cláudia Marchetti, Chiara Brando, et al.. (2025). BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study. ESMO Open. 10(2). 104076–104076. 2 indexed citations
2.
Buglioni, Simonetta, Fabio Pagni, Nicola Fusco, et al.. (2025). Part III – Post-analytical phase. Pathologica. 117(2). 36–36. 1 indexed citations
3.
Russo, Tancredi Didier Bazan, Francesco Pepe, Valerio Gristina, et al.. (2025). Recent advances in liquid biopsy for precision oncology: emerging biomarkers and clinical applications in lung cancer. Future Oncology. 21(21). 2803–2821. 1 indexed citations
4.
Incorvaia, Lorena, Tancredi Didier Bazan Russo, Valerio Gristina, et al.. (2024). The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors. npj Precision Oncology. 8(1). 190–190. 10 indexed citations
5.
Pavan, Nicola, Fabio Fulfaro, Valerio Gristina, et al.. (2024). Applications of Platelet Concentrates (PCs) in Regenerative Onco-Urology: A Systematic Review of Literature. International Journal of Molecular Sciences. 25(19). 10683–10683.
6.
Russo, Tancredi Didier Bazan, Alessandro Perez, Marco Bono, et al.. (2024). Exploring the potential of multiomics liquid biopsy testing in the clinical setting of lung cancer. Cytopathology. 35(6). 664–670. 6 indexed citations
7.
Gristina, Valerio, Alessandro Perez, Nadia Barraco, et al.. (2024). Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. “Re-discovering the neglected biosources of the liquid biopsy family”. SHILAP Revista de lepidopterología. 3. 100136–100136. 8 indexed citations
8.
Incorvaia, Lorena, Chiara Brando, Alessandro Perez, et al.. (2023). Real life use of biomarkers of homologous recombination deficiency (HRD) status beyond BRCA to predict the effectiveness of PARP inhibitors in ovarian cancer patients.. Journal of Clinical Oncology. 41(16_suppl). 10592–10592.
9.
Peri, Marta, Giuseppe Roberto Giammalva, Antonino Lupica, et al.. (2023). Immunological Aspects of Von Hippel-Lindau Disease: A Focus on Neuro-Oncology and Myasthenia Gravis. Diagnostics. 13(1). 144–144. 5 indexed citations
10.
Cammarata, Giuseppe, Nadia Barraco, Ilaria Giusti, et al.. (2022). Extracellular Vesicles-ceRNAs as Ovarian Cancer Biomarkers: Looking into circRNA-miRNA-mRNA Code. Cancers. 14(14). 3404–3404. 30 indexed citations
11.
Viscardi, Giuseppe, Fabiana Vitiello, Alberto Servetto, et al.. (2022). Moving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review. Cancers. 14(23). 5810–5810. 4 indexed citations
12.
Gristina, Valerio, Marta Peri, Nadia Barraco, et al.. (2022). Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer: Making the invisible visible. Critical Reviews in Oncology/Hematology. 182. 103899–103899. 14 indexed citations
13.
Pisapia, Pasquale, Francesco Pepe, Valerio Gristina, et al.. (2021). A narrative review on the implementation of liquid biopsy as a diagnostic tool in thoracic tumors during the COVID-19 pandemic. Mediastinum. 5. 27–27. 14 indexed citations
14.
Passiglia, Francesco, Antonio Galvano, Valerio Gristina, et al.. (2021). Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?—a trial-level meta-analysis in PD-L1 selected subgroups. Translational Lung Cancer Research. 10(7). 3106–3119. 20 indexed citations
17.
Galvano, Antonio, Marta Castiglia, Valerio Gristina, et al.. (2020). Cell-free DNA and exoDNA analysis in metastatic colorectal cancer patients (mCRC).. Journal of Clinical Oncology. 38(15_suppl). e16093–e16093. 1 indexed citations
18.
Incorvaia, Lorena, Daniele Fanale, Giuseppe Badalamenti, et al.. (2019). Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC). Advances in Therapy. 36(10). 2600–2617. 76 indexed citations
19.
Blasi, Livio, et al.. (2018). Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer. Drug Design Development and Therapy. Volume 12. 1769–1775. 18 indexed citations
20.
Gristina, Valerio, et al.. (2014). Diabetes and cancer: A critical appraisal of the pathogenetic and therapeutic links. Biomedical Reports. 3(2). 131–136. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026